## COST: Costco Wholesale Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -2.8% below STRENGTH zone (3.0-6.0%); PEG 4.78 fails VALUE criteria (<1.0); RSI 30 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($819.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Assessing Costco (COST) Valuation After a 10% Pullback in Shareholder Returns**
- Source: Simply Wall Street | 20251222T234118 | Neutral | Relevance: 100%
- Costco Wholesale (COST) has experienced a 10% pullback in shareholder returns over the past year, despite its strong long-term track record. While some analysts view the stock as undervalued with a fair value around $1,056, others point to its rich valuation multiples compared to its industry. The article explores whether this pullback presents an entry point or if the market has already factored in future growth.

**2. Costco Stock (COST) Before the Market Open on Dec. 22, 2025: Key News, Earnings Takeaways, Analyst Forecasts, and What to Watch**
- Source: ts2.tech | 20251222T020834 | Somewhat-Bullish | Relevance: 100%
- Costco Wholesale Corporation (NASDAQ: COST) is heading into the December 22, 2025, trading session with solid business fundamentals but facing a valuation debate after a year of relative underperformance. The article details Costco's Q1 fiscal 2026 results, highlighting strong sales, stable margins, and significant digital growth, alongside crucial membership trends that are central to investor focus. Key areas to watch include membership renewal trajectories, new legal updates regarding tariffs, and analyst forecasts that show a "Buy" consensus despite valuation concerns.

**3. Jim Cramer Says Victory Against Tariffs Could Finally Pull Costco Stock "From Its Continued, and Endless, and Terrible Tailspin"**
- Source: Finviz | 20251221T100801 | Neutral | Relevance: 100%
- Jim Cramer highlighted that Costco Wholesale Corporation (COST) is suing the current administration over tariffs, suggesting that a victory could significantly boost the stock. He expressed concerns about recent management changes and slower monthly sign-ups but is not yet "throwing in the towel" despite his usual high regard for the company. Cramer believes that freeing Costco from tariff burdens could finally end its perceived "tailspin."

**4. Costco rolls out major checkout change â€“ and it will affect your spot in line**
- Source: The US Sun | 20251222T185403 | Somewhat-Bullish | Relevance: 100%
- Costco is implementing a significant change to its checkout process by moving self-checkout lanes to the end of its warehouses, a move shoppers are calling "efficient." This alteration aims to create uniformity across stores and improve traffic flow. While many shoppers praise the change for potentially reducing lines and delays, concerns have been raised about increased shoplifting risks.

**5. Guggenheim maintains Neutral rating on Costco stock amid concerns**
- Source: Investing.com | 20251222T130314 | Somewhat-Bearish | Relevance: 100%
- Guggenheim has reiterated its Neutral rating on Costco Wholesale (NASDAQ:COST) due to investor concerns about softening metrics and the stock's elevated valuation. The company's P/E ratio of 46.2 is significantly above industry averages, and its stock has pulled back 11% over the past six months, contrasting with the S&P 500's rally. Analyst outlooks on Costco are varied, with TD Cowen and UBS maintaining Buy ratings, while Roth/MKM downgraded to a Sell.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 2, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $900 | $1000 | -10% |
| 2025-12-15 | Roth Capital | $769 | $906 | -15% |
| 2025-12-12 | JP Morgan | $1027 | $1025 | +0% |
| 2025-12-12 | Goldman Sachs | $1171 | $1218 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | main | Equal-Weight |
| 2025-12-15 | Roth Capital | down | Sell |
| 2025-12-12 | JP Morgan | main | Overweight |
| 2025-12-12 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.00M) |
| Sells | 11 ($11.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+0.2%)
- Blackrock Inc.: 7.8% (-2.2%)
- State Street Corpora: 4.1% (-0.9%)
- Geode Capital Manage: 2.3% (+0.8%)
- Morgan Stanley: 2.1% (-1.6%)

### Key Risks

1. Heavy insider selling: $12M sold (11 transactions in 90 days).
2. Valuation stretched: PEG 4.8x requires aggressive growth execution.
3. Long-term trend broken: trading 10.8% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.78 signals overvaluation risk, limited margin of safety. Forward P/E 38.2x stretched relative to 10% growth. Quality metrics strong (ROE 30%). Balance sheet: $3.2B free cash flow. Analyst sentiment negative (4 target cuts vs 2 raises). Insider selling cluster ($11.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $377.4B |
| Beta | 0.98 |
| 52W Range | $844.06 - $1078.23 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.78 |
| Forward P/E | 38.2 |
| Current P/E | 41.9 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -1.5% to -2.8% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.89x), long-term trend not supportive. MACD histogram bearish (-3.23), momentum weakening. RSI oversold at 30, potential bounce setup. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.76% (CS: 11) | Weak |
| RSI_14 | 29.7 | Oversold |
| MACD Histogram | -3.23 | Bearish |
| vs SMA20 | 0.960x | Below |
| vs SMA50 | 0.935x | Below |
| vs SMA200 | 0.892x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $850.00
- **Stop Loss:** $819.48 (3.6% risk)
- **Target:** $880.52 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 19
- **Position Value:** $16,150.00
- **Portfolio %:** 16.15%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.28 | $4.50 | +5.2% |
| 2025Q3 | $5.81 | $5.87 | +1.1% |
| 2025Q2 | $4.23 | $4.28 | +1.2% |
| 2025Q1 | $4.10 | $4.02 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*